Evolution of Biomarker Testing and Overview of Liquid Biopsy Using ctDNA

Download these slides from our 2020 ASCO-GI live satellite symposium on biomarkers to review the current state of biomarker testing and liquid biopsy using cell-free circulating tumor DNA.
Pashtoon Kasi, MD
John L. Marshall, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 3.13 MB
Released: January 23, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Array BioPharma Inc.
Bayer HealthCare Pharmaceuticals Inc.
Merck Sharp & Dohme Corp.

Related Content

Gain key insights quickly with this short slideset from Clinical Care Options (CCO) on HER2 testing and targeted therapy in advanced GI cancers

Axel Grothey Headshot Axel Grothey, MD Michael F. Press, MD, PhD Released: September 30, 2020

In this slideset from Clinical Care Options (CCO), experts provide insights on HER2 testing and targeted therapy in advanced gastrointestinal cancers

Axel Grothey Headshot Axel Grothey, MD Michael F. Press, MD, PhD Released: September 25, 2020

Downloadable slideset covering the latest data on treating patients with pancreatic cancer and BRCA mutations or other actionable alterations, from Clinical Care Options (CCO)

person default Dirk Arnold, MD, PhD Released: September 21, 2020

Downloadable slideset reviewing the latest data on molecular testing considerations for patients with pancreatic cancer, from Clinical Care Options (CCO)

Michael J. Pishvaian, MD, PhD Released: September 21, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue